BioCentury
ARTICLE | Clinical News

Athena regulatory update

April 22, 1996 7:00 AM UTC

ATHN said Duke University received U.S. Patent No. 5,508,167 covering the use of apolipoprotein E (ApoE) in methods for diagnosing Alzheimer's disease. ATHN is the exclusive licensee to the patent, w...